Cormedix Affirms FY2026 Sales Guidance of $325.000M-$345.000M vs $334.089M Est

Benzinga Newsdesk www.benzinga.com Negative 62.9%

Neg 62.9% Neu 0% Pos 0%

Cormedix (NASDAQ:CRMD) affirms FY2026 sales outlook from $325.000 million-$345.000 million to $325.000 million-$345.000 million vs $334.089 million estimate.